A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
Condition:   Gastric Cancer Interventions:   Drug: RC48-ADC;   Drug: Herceptin;   Drug: Toripalimab;   Drug: Oxaliplatin injection;   Drug: Capecitabine Sponsor:   RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
Condition:   Breast Neoplasms Interventions:   Drug: Trilaciclib;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab Sponsor:   wang shusen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials